KARACA, Ş. B. Et Al. 2014. Effect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling. ASCO Annual Meeting , (CHICAGO, United States Of America), 13512.

KARACA, Ş. B., BOZKURT, E., ATMACA, H., SÜRMELİ, Z. G., ERDOĞAN, A. P., ŞANLI, U. A., ... USLU, R.(2014). Effect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling . ASCO Annual Meeting (pp.13512). CHICAGO, United States Of America

KARACA, ŞAZİYE Et Al. "Effect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling," ASCO Annual Meeting, CHICAGO, United States Of America, 2014

KARACA, ŞAZİYE B. Et Al. "Effect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling." ASCO Annual Meeting , CHICAGO, United States Of America, pp.13512, 2014

KARACA, Ş. B. Et Al. (2014) . "Effect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling." ASCO Annual Meeting , CHICAGO, United States Of America, p.13512.

@conferencepaper{conferencepaper, author={ŞAZİYE BURÇAK KARACA Et Al. }, title={Effect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling}, congress name={ASCO Annual Meeting}, city={CHICAGO}, country={United States Of America}, year={2014}, pages={13512} }